Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
3(19%)
Results Posted
50%(2 trials)

Phase Distribution

Ph not_applicable
7
44%
Ph phase_2
1
6%
Ph phase_4
1
6%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
1(11.1%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
7(77.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

16

all time

Status Distribution
Active(6)
Completed(4)
Other(6)

Detailed Status

unknown6
Completed4
Recruiting3
Enrolling by invitation2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
16
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (11.1%)
Phase 41 (11.1%)
N/A7 (77.8%)

Trials by Status

enrolling_by_invitation213%
completed425%
not_yet_recruiting16%
recruiting319%
unknown638%

Recent Activity

Clinical Trials (16)

Showing 16 of 16 trials
NCT07130994Not Applicable

Reduction or Elimination of Mitral Regurgitation With the SATURN TMVR System (CASSINI-US)

Recruiting
NCT02276547Not Applicable

Early Feasibility Study of the Neovasc Tiara™ Mitral Valve System

Completed
NCT07243184Not Applicable

The Feasibility Study of Polymer Artificial Heart Valve for the Treatment the Mitral Valve Disease.

Recruiting
NCT05090540

Transcatheter Versus Standard Surgical Mitral Valve Operation for Secondary Mitral Regurgitation

Enrolling By Invitation
NCT07151989

Influence of Original Native Mitral Valve Lesion (Stenosis or Steno-insufficiency vs. Insufficiency) on Post-implant Structural Bioprosthetic Degeneration After Mitral Valve Replacement

Enrolling By Invitation
NCT06811662Not Applicable

Outcomes of Complete Versus Partial Preservation of the Sub-valvular Apparatus in Cases of Mitral Valve Replacement

Not Yet Recruiting
NCT05898230

Retrospective Clinical Data Collection on Carbomedics OptiForm Mitral Heart Valve

Recruiting
NCT06191718Not Applicable

Clinical Investigation for the Foldax Tria Mitral Valve- India

Unknown
NCT05839782

Long Term Results in Redo Mitral Valve Surgery After Mitral Valve Repair

Completed
NCT05594420

Bleeding and Blood Transfusion in MVR

Unknown
NCT03195595

Minimal Invasive Mitral Valve Replacement Versus Conventional Median Sternotomy Approach

Unknown
NCT03870516Not Applicable

Left Chamber Function in Mitral Regurgitation and Predicting Outcome After Replacement and Targeting for Early Surgery

Unknown
NCT03885570

Blood Transfusion Management in Patients With Mitral Valve Replacement in China

Unknown
NCT00807040Phase 2

Comparing the Effectiveness of Repairing Versus Replacing the Heart's Mitral Valve in People With Severe Chronic Ischemic Mitral Regurgitation

Completed
NCT02719912Not Applicable

Mitral Valve Replacement With MValve Dock and Lotus

Unknown
NCT01641614Phase 4

Beating Versus Arrested Heart for Mitral Valve Replacement

Completed

All 16 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
16